DANIEL BRADBURY Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL BRADBURY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL BRADBURY. DANIEL BRADBURY is Executive Vice President in AMYLIN PHARMACEUTICALS INC ($AMLN) and Director in GERON CORP ($GERN) and Director in ILLUMINA INC ($ILMN) and Director in CORCEPT THERAPEUTICS INC ($CORT) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in BioMed Realty Trust Inc ($BMR) and Director in CASTLE BIOSCIENCES INC ($CSTL) and Chief Executive Officer in Equillium, Inc. ($EQ) and Director in Nuvation Bio Inc. ($PANA).
DANIEL BRADBURY in INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL BRADBURY: Director
Holdings: 15,811 shares
Current Value: $1,795,655
Latest Transaction: Jun 01 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL BRADBURY in INTERCEPT PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMLN, BMR, CSTL, CORT, EQ, GERN, ILMN, ICPT, NUVB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 17.08 | 12,089 | 206,480 | 12,089 | |
| Jun 01 2021 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 7,029 | 0 | 15,811 | 8.8 K to 15.8 K (+80.04 %) |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 72.74 | 2,966 | 215,747 | 2,966 | |
| Jun 01 2020 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 1,595 | 0 | 8,782 | 7.2 K to 8.8 K (+22.19 %) |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 82.25 | 2,174 | 178,812 | 2,174 | |
| Jun 21 2019 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 1,570 | 0 | 7,187 | 5.6 K to 7.2 K (+27.95 %) |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 85.12 | 2,748 | 233,910 | 2,748 | |
| Jun 22 2018 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 1,787 | 0 | 13,429 | 11.6 K to 13.4 K (+15.35 %) |
| Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Buy | P | 64.00 | 7,812 | 499,968 | 11,642 | 3.8 K to 11.6 K (+203.97 %) |
| Apr 09 2018 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Buy | P | 64.00 | 7,812 | 499,968 | 11,642 | 3.8 K to 11.6 K (+203.97 %) |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 122.01 | 2,036 | 248,412 | 2,036 | |
| Jun 29 2017 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 1,423 | 0 | 3,830 | 2.4 K to 3.8 K (+59.12 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 145.22 | 3,196 | 464,123 | 3,196 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 2,407 | 0 | 2,407 | 0 to 2.4 K |
Page: 1